Thanks, we’ll be in touch.

Thanks for joining our community. We’ll be sure to keep you up to date on what’s new – in the meantime, learn about the latest clinical evidence supporting the CathWorks FFRangio® System.

FFRangio Validation Study

The FFRangio Validation study evaluated 203 lesions in 184 patients and showed that there is high concordance between FFRangio and invasive FFR, including a diagnostic accuracy of 93%.

Read More arrow_forward

FAST-FFR Pivotal Trial

The FAST-FFR pivotal trial was a prospective multicenter, international trial designed to determine the accuracy of FFRangio in clinical practice compared to traditional wire-based FFR. The trial included 301 patients and 319 vessels at 10 clinical sites.

Read More arrow_forward

FFRangio in Dual/Triple Vessel Disease

This prospective clinical study conducted at Gifu Heart Centre, Japan—evaluated the diagnostic performance of FFRangio in 50 patients with dual or triple vessel CAD compared to wire-based FFR.

Read More arrow_forward

FFRangio Pooled Analysis from 5 Prospective Cohort Studies

This lesion-level pooled data analysis of 588 patients and 700 lesions represents the “largest and most diverse cohort of any single angiogram-based FFR technology reported.”

Read More arrow_forward
expand_lessBack to top of page

We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. Terms and Conditions